XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | 71.47%770.27M | ---- | ---- | ---- | -54.06%449.23M | ---- | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | 87.34%-8.21M | ---- | ---- | ---- | 35.01%-64.85M | ---- | ---- |
Interest expense - adjustment | ---- | ---- | ---- | 102.01%171.92M | ---- | ---- | ---- | 253.40%85.11M | ---- | ---- |
Dividend (income)- adjustment | ---- | ---- | ---- | -84.00%-920K | ---- | ---- | ---- | 17.22%-500K | ---- | ---- |
Investment loss (gain) | ---- | ---- | ---- | 26.86%-6.86M | ---- | ---- | ---- | -35.09%-9.39M | ---- | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | ---- | -95.52%-691.3M | ---- | ---- | ---- | 46.17%-353.56M | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 103.86%469K | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 555.34%469K | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | 28.86%237.65M | ---- | ---- | ---- | -16.34%184.43M | ---- | ---- |
-Amortization of intangible assets | ---- | ---- | ---- | 30.86%206.53M | ---- | ---- | ---- | -14.16%157.83M | ---- | ---- |
Exchange Loss (gain) | ---- | ---- | ---- | -37.46%9.15M | ---- | ---- | ---- | 293.26%14.63M | ---- | ---- |
Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---57K | ---- | ---- |
Operating profit before the change of operating capital | ---- | ---- | ---- | 57.67%481.7M | ---- | ---- | ---- | -30.34%305.51M | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | 115.00%215K | ---- | ---- | ---- | 166.67%100K | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | -119.93%-10.47M | ---- | ---- | ---- | 134.64%52.56M | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | 99.62%-990K | ---- | ---- | ---- | 66.21%-259.51M | ---- | ---- |
Cash from business operations | 9.48%437.55M | -5.35%287.7M | -62.38%73.43M | 376.84%470.45M | 590.77%399.65M | 27.27%303.96M | --195.18M | 120.50%98.66M | --57.86M | --238.84M |
Other taxs | 97.61%-62K | 98.54%-33K | ---- | 77.36%-2.6M | 83.22%-2.6M | 80.79%-2.26M | ---486K | 92.43%-11.48M | ---15.49M | ---11.76M |
Net cash from operations | 10.19%437.49M | -4.65%287.67M | -62.29%73.43M | 436.66%467.85M | 837.09%397.05M | 32.86%301.7M | 231.70%194.7M | 113.77%87.18M | 123.16%42.37M | 234.07%227.08M |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | ---- | ---- | -93.20%4.43M | -82.70%4.43M | -81.98%4.43M | -45.62%3.73M | -49.12%65.18M | -14.65%25.62M | 34.62%24.6M |
Dividend received - investment | -44.28%158.64M | ---- | ---- | -35.16%390.95M | 33.04%284.72M | --182.21M | --181.38M | -22.41%602.92M | -60.27%214.01M | ---- |
Loan receivable (increase) decrease | ---- | ---- | ---- | 296.83%210M | 296.83%210M | 296.83%210M | ---- | 115.38%52.92M | 113.78%52.92M | 110.06%52.92M |
Decrease in deposits (increase) | 56.41%-510M | 46.75%-410M | 16.22%-310M | -1.36%-1.49B | ---1.17B | ---770M | -609.25%-370M | -747.53%-1.47B | ---- | ---- |
Sale of fixed assets | --13K | --13K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | -91.36%-263.87M | -93.56%-261.53M | -127.36%-203.78M | 2.98%-308.78M | 30.55%-137.9M | -8,049.52%-135.12M | ---89.63M | -33,157.47%-318.27M | -268,229.73%-198.56M | -2,140.54%-1.66M |
Recovery of cash from investments | -53.27%573.13M | -53.93%472.47M | -28.43%322.05M | 3.67%1.43B | 40.14%1.23B | 190.15%1.03B | 28.57%450M | -8.30%1.38B | -49.56%875.22M | -67.87%353.45M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 20.41%-768M | 49.23%-352.84M |
Net cash from investment operations | -110.08%-42.1M | -138.50%-199.05M | -209.26%-191.73M | -24.34%234.53M | 107.64%417.77M | 576.12%517.06M | -49.31%175.48M | -57.25%310M | -78.92%201.2M | -87.10%76.48M |
Net cash before financing | -51.47%395.39M | -89.18%88.62M | -131.96%-118.3M | 76.85%702.39M | 234.53%814.82M | 169.73%818.76M | -8.57%370.18M | 330.76%397.18M | -68.44%243.57M | -28.30%303.55M |
Cash flow from financing activities | ||||||||||
New borrowing | 81.50%1.52B | 9.83%916.75M | --75.47M | -49.39%1.2B | 44.44%838.57M | 56.06%834.69M | ---- | -3.53%2.38B | -69.39%580.55M | -59.71%534.83M |
Refund | 2.87%-1.19B | 14.58%-890.78M | ---- | 59.85%-1.44B | -135.13%-1.23B | -110.10%-1.04B | 93.88%-26.42M | -128.01%-3.59B | 59.20%-522.5M | 50.41%-496.33M |
Interest paid - financing | -2.77%-126.98M | -10.85%-88M | -17.90%-44M | -97.29%-167.9M | -350.40%-123.56M | -458.09%-79.38M | -453.10%-37.32M | -314.89%-85.11M | -94.35%-27.43M | -63.38%-14.22M |
Dividends paid - financing | -228.68%-366.48M | ---- | ---- | 43.93%-287.38M | 67.11%-111.5M | ---6.1M | ---3.38M | 41.68%-512.56M | 42.56%-338.98M | ---- |
Issuance expenses and redemption of securities expenses | ---176K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items of the financing business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -41.83%30.16M | ---- | ---- |
Net cash from financing operations | 73.39%-166.83M | 78.62%-63.1M | 144.29%30.7M | 60.99%-696.19M | -102.89%-627.04M | -1,351.17%-295.1M | -7,100.81%-69.31M | -4,265.60%-1.78B | -2,769.30%-309.05M | 113.95%23.59M |
Effect of rate | -318.37%-7.93M | -68.61%895K | 162.54%389K | 119.35%3.4M | 305.13%3.63M | 391.55%2.85M | ---622K | -17.38%1.55M | -52.32%896K | -71.39%580K |
Net Cash | 21.72%228.56M | -95.13%25.51M | -129.12%-87.6M | 100.45%6.2M | 386.77%187.78M | 60.07%523.66M | -25.87%300.87M | -1,127.44%-1.39B | -108.36%-65.48M | -24.69%327.14M |
Begining period cash | 2.03%483.62M | 2.03%483.62M | 2.03%483.62M | -74.52%474.02M | -74.52%474.02M | -72.03%474.02M | -74.52%474.02M | 7.95%1.86B | 258.35%1.86B | 226.46%1.69B |
Cash at the end | 5.83%704.25M | -49.02%510.03M | -48.80%396.4M | 2.03%483.62M | -62.94%665.43M | -50.52%1B | -65.83%774.26M | -74.52%474.02M | 37.66%1.8B | 111.64%2.02B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | KPMG | -- | -- | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.